Aethlon Medical Q2 2026 Results: Net Loss of $2.62M, Loss Widens
Aethlon Medical reported a net loss of $4.17 million for the six months ended September 30, 2026, compared to $3.25 million in the prior year period, driven largely by increased professional fees. The company is currently pursuing a merger with North Immunology, Inc. and has raised capital through common stock issuances to maintain a cash balance of approximately $6.49 million.
- Key figure
- Net loss $2.62M